Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05537064 · ClinicalTrials.gov registry record · NA
Centralized Prescribing for Statins
A NA study of Hyperlipidemias, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 1,950
- Enrollment target
- 1
- Study location
NCT05537064: Active NA study of Hyperlipidemias, sponsored by University of Pennsylvania.
NCT05537064 is a NA study of Hyperlipidemias that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 1,950 participants, below the 3,928-participant average among 21 other Hyperlipidemias trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05537064, a NA study of Hyperlipidemias, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,950 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study consists of a pair of pragmatic clinical trials that will evaluate two separate methods for optimizing referral of eligible patients to a centralized pharmacy service for statin management: 1) A stepped wedge clinical trial, with randomization at the level of the provider, evaluating a visit-based nudge for referral to pharmacy services versus usual care; 2) A cluster randomized trial, with randomization at the level of the practice, evaluating a non-visit based nudge for referral to pharmacy services versus usual care.
Primary Outcome
The primary outcome is the prescription of a statin for eligible patients during the 9-month timeframe, assessed among all patients assigned to the physician or office eligible for but not prescribed a high-intensity statin at the start of the trial. The primary outcome will be compared between patients seeing physicians, or seen at practices, randomized to the intervention vs. usual care.
Conditions Studied
Interventions
- BEHAVIORAL Non-visit Based Intervention
- BEHAVIORAL Visit-Based Intervention
Study Locations (1)
Pennsylvania
- Lancaster General Hospital - Lancaster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,950 participants |
| Start Date | 2022-11-02 |
| Est. Completion | 2026-02 |
| Phase | NA |
What the registry record for NCT05537064 still lists
NCT05537064 is an interventional study that assigns participants to a tested intervention. Its 1,950 participants enrollment target places it among the larger protocols in the corpus, below the 3,928-participant average among 21 other Hyperlipidemias trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Hyperlipidemias appearing as the primary indexed condition, and to 2 interventions - of which Non-visit Based Intervention is the first listed.
NCT05537064 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05537064 about?
NCT05537064 is a clinical study titled "Centralized Prescribing for Statins". This pilot study consists of a pair of pragmatic clinical trials that will evaluate two separate methods for optimizing referral of eligible patients to a centralized pharmacy service for statin management: 1) A stepped wedge clinical trial, with randomization at the level of the provider, evaluatin...
What is the current status of trial NCT05537064?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,950 participants. The study started on 2022-11-02. Estimated completion is 2026-02.
What conditions does trial NCT05537064 study?
This clinical trial studies the following conditions: Hyperlipidemias.
What interventions are being tested in trial NCT05537064?
The interventions under investigation include: Non-visit Based Intervention (BEHAVIORAL), Visit-Based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05537064?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05537064 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperlipidemias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05537064's enrollment target sits among peer trials
1,950 4th of 21 higher than 18 of 21 other Hyperlipidemias trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hyperlipidemias trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Penn Medicine Healthy Heart
RECRUITING · NA
-
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
RECRUITING · NA
-
Social Needs Screening and Chronic Diseases Study (WE CARE)
RECRUITING · NA
-
Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome
ACTIVE NOT RECRUITING · NA
-
Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
- NCT07321886 · 1,980 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- NCT06058455 · 1,920 participants · NA
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI